Venture Funding Deals: Locana Gets Ready To Take On ALS, Huntington's With Gene Editing
Executive Summary
The series A fundraising will help Locana bring CRISPR gene editing to diseases with dysfunctional RNA. Artizan and OncoMyx are among the other firms with recent series A rounds.